Karen Akinsanya Sells 10,242 Shares of Schrödinger, Inc. (NASDAQ:SDGR) Stock

Schrödinger, Inc. (NASDAQ:SDGR) insider Karen Akinsanya sold 10,242 shares of the firm’s stock in a transaction that occurred on Tuesday, June 8th. The shares were sold at an average price of $75.54, for a total transaction of $773,680.68. Following the completion of the sale, the insider now directly owns 6,479 shares of the company’s stock, valued at approximately $489,423.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

NASDAQ SDGR opened at $76.41 on Friday. Schrödinger, Inc. has a 12 month low of $46.27 and a 12 month high of $117.00. The firm has a 50-day moving average of $71.34. The company has a market capitalization of $5.39 billion, a P/E ratio of -424.48 and a beta of 0.96.

Several institutional investors have recently bought and sold shares of SDGR. Stephens Inc. AR bought a new stake in shares of Schrödinger in the 1st quarter valued at about $29,000. Signaturefd LLC bought a new stake in Schrödinger in the fourth quarter valued at approximately $36,000. Arkadios Wealth Advisors raised its holdings in Schrödinger by 82.3% in the first quarter. Arkadios Wealth Advisors now owns 483 shares of the company’s stock worth $36,000 after purchasing an additional 218 shares during the period. TCI Wealth Advisors Inc. acquired a new stake in Schrödinger in the first quarter worth $39,000. Finally, Valeo Financial Advisors LLC boosted its position in shares of Schrödinger by 22.4% during the fourth quarter. Valeo Financial Advisors LLC now owns 601 shares of the company’s stock worth $48,000 after purchasing an additional 110 shares in the last quarter. Institutional investors own 50.09% of the company’s stock.

A number of research analysts have commented on SDGR shares. Craig Hallum initiated coverage on Schrödinger in a research report on Tuesday, May 25th. They issued a “buy” rating and a $85.00 price objective on the stock. Zacks Investment Research upgraded Schrödinger from a “sell” rating to a “hold” rating in a report on Thursday, May 13th. Morgan Stanley dropped their price objective on Schrödinger from $89.00 to $83.00 and set an “equal weight” rating for the company in a report on Wednesday, May 12th. Finally, BMO Capital Markets cut their target price on shares of Schrödinger from $110.00 to $104.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 24th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $85.67.

About Schrödinger

Schrödinger, Inc provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.

Featured Article: Float

Insider Buying and Selling by Quarter for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.